QUANTUM X LABS INC. quarterly report, Q2 FY2011

Business context and reporting period

The filing is a Form 10-Q for the quarter and six months ended June 30, 2011. The document identifies the registrant as Zaxis International Inc., not Quantum X Labs Inc.; verify the filing-to-company match. Zaxis had no current operations and was seeking a business combination. Its former biotechnology operations ceased in 2002.

Financial results and liquidity

MetricThree months ended June 30, 2011Six months ended June 30, 2011
Revenue$0$0
General and administrative expense$9,530$21,430
Interest expense$1,050$2,100
Net loss$10,580$23,530
Basic and diluted loss per share$0.01$0.01

For the comparable 2010 periods, revenue was also $0; quarterly net loss was $10,779 and six-month net loss was $23,329. Gross and operating margins are not meaningful given no revenue and no operating business. Six-month operating, investing, and financing cash flows were each reported as $0; cash was $0 at both June 30, 2011 and December 31, 2010.

At June 30, 2011, the company reported no assets, current liabilities of $118,379, total liabilities of $153,379, and stockholders’ deficiency of $153,379. Liabilities included $110,529 due to related parties and a $35,000 related-party convertible note. Accumulated deficit was $274,794. The company reported 1,695,126 shares outstanding, up from 1,495,126 at year-end 2010.

Material changes versus the prior comparable period

Six-month net loss increased by $201 from 2010, while quarterly net loss improved by $199. Total liabilities increased by $9,530 from December 31, 2010, and shares outstanding increased by 200,000. The filing reports $18,000 of noncash related-party services for the first half of 2011, matching the 2010 amount.

Outlook, risks, and other disclosures

Management’s plan was to seek a business combination; no target business or industry had been selected. Management noted that a transaction could require substantial share issuance, diluting existing holders and potentially changing control. It also described the likelihood of completing only one combination, limited resources, and uncertainty about obtaining financing.

The filing states that insufficient working capital is available for operating needs over the next twelve months and that accumulated losses raise substantial doubt about the company’s ability to continue as a going concern. No forward financial guidance was provided. Management concluded disclosure controls were effective and reported no material change in internal control over financial reporting. The filing reported no legal proceedings or unregistered securities sales; it refers investors to the 2010 Form 10-K for risk factors.

Key facts for investors to verify

  • Confirm the registrant identity: the supplied filing is for Zaxis International Inc., despite the request metadata naming Quantum X Labs Inc.
  • Review the related-party advances, accrued amounts, and $35,000 convertible note, including their terms and repayment prospects.
  • Assess the going-concern warning, zero cash balance, and the company’s ability to fund operations or complete a business combination.
  • Verify the 200,000-share increase and potential dilution or change of control from a future transaction.
  • Confirm the reported zero cash flows and the accounting for noncash related-party services.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.